GENERIC IMATINIB: A COST-EFFECTIVE OPTION?

The arrival of common imatinib represents a substantial opportunity for patients battling CML and other illnesses. Original brand-name imatinib, branded as Gleevec, carries a steep price cost, frequently causing accessibility for some individuals. Off-brand versions, generally manufactured by var